Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback